Market Overview:
The global small-molecule drug discovery market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic diseases, rising R&D expenditure by pharmaceutical and biotechnology companies, and technological advancements in drug discovery platforms. Based on type, the small-molecule drug discovery market can be segmented into pills, tablets, and others. Pills are expected to account for the largest share of this market in 2018 owing to their high adoption rates across various applications. By application, the small-molecule drug discovery market can be divided into oncology, cardiovascular diseases (CVDs), dermatology, central nervous system (CNS) disorders, respiratory disorders such as asthma and COPD), gastrointestinal disorders (such as irritable bowel syndrome [IBS] and Crohn’s disease), and others. Oncology is expected to account for the largest share of this market in 2018 owing to rising incidence rates of cancer globally.
Product Definition:
Small-molecule drug discovery is the process of finding and developing new small-molecule drugs. The importance of small-molecule drug discovery is that they can be more selective in their actions than larger molecules, and they can cross the blood-brain barrier more easily.
Pills:
Pills is a software platform that automates the process of identification, optimization, and selection of small molecule target compounds. It also helps in generating high quality leads with improved speed and accuracy. The growth factor for this market is increasing demand for efficient drug discovery methods due to the growing number of novel targets being identified by research institutes across the globe.
Increasing R&D investments by pharmaceutical companies coupled with rising government funding are some factors driving this market globally.
Tablets:
Tablets are small, rigid and flat containers made from a variety of materials including glass, plastic and aluminum. They can be used to store dry or liquid drugs. Tablets have the advantage of being easy to handle as compared to capsules; they also provide for convenient packaging and display on retail shelves.
Application Insights:
On the basis of application, the global small-molecule drug discovery market has been segmented into oncology, cardiovascular, dermatology, central nervous system, respiratory and gastrointestinal. Oncology dominated this market in 2017 owing to several factors such as increasing prevalence of cancer and rising investment by companies for R&D pertaining to oncology drugs. Moreover, an increase in approvals for new products is also expected to drive growth during the forecast period.
Cardiovascular is anticipated to be one of the fastest growing segments over the forecast period owing to factors such as increased government funding towards research related Cardiovascular Small Molecule Drugs (CSMDs) and presence of a strong pipeline with multiple Phase III clinical trials ongoing or completed succesfully.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of small-molecule drug developers and their efforts to find new molecules for treatment options for various diseases. The region is expected to maintain its dominance over the forecast period as well owing to factors such as favorable government policies, high healthcare expenditure, and technological advancements in research laboratories.
Asia Pacific is anticipated to witness lucrative growth during the forecast period due to factors such as rising disposable income, improving healthcare infrastructure & availability of medicines, increasing awareness about early diagnosis & treatment options for various diseases especially cancer and cardiovascular disorders are anticipated boost revenue generation from small-molecule drugs over this period. ‘’The Asia Pacific has one of the largest populations with respect both clinically and statistically with regard specific disease states (i.e., cancer) or conditions (i.e., diabetes).
Growth Factors:
- Increasing prevalence of chronic diseases: The increasing prevalence of chronic diseases is one of the key growth drivers for the small-molecule drug discovery market. According to a study by the World Health Organization (WHO), chronic diseases account for 60% to 70% of all deaths globally. This is attributed to the changing lifestyles and dietary habits, which has led to an increase in the incidence of chronic diseases such as cancer, diabetes, and heart disease.
- Rising demand for novel therapeutics: The growing demand for novel therapeutics is another major factor driving growth in the small-molecule drug discovery market. Due to advances in medical technology and rising consumer awareness about health issues, patients are increasingly seeking newer and more effective treatments for their conditions. This has led to an increased demand for novel small-molecule drugs that can provide better outcomes than existing therapies.
- Emergence of targeted therapies: The emergence of targeted therapies is another key trend that is expected to drive growth in the small-molecule drug discovery market over the next few years. Targeted therapies are designed specifically to treat a particular type or stage of cancer, which allows them be more effective than traditional chemotherapy regimens that treat all types tumors indiscriminately . As a result, there is increasing interest among pharmaceutical companies in developing targeted small-molecule drugs as new treatment options for various cancers .
Scope Of The Report
Report Attributes
Report Details
Report Title
Small-Molecule Drug Discovery Market Research Report
By Type
Pills, Tablets, Others
By Application
Oncology, Cardiovascular, Dermatology, Central Nervous System, Respiratory, Gastrointestinal, Others
By Companies
Pfizer, Merck, Bristol-Myers Squibb, GlaxoSmithKline, Boehringer Ingelheim, AstraZeneca, Johnson & Johnson, Teva Pharmaceuticals, Gilead Sciences Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
164
Number of Tables & Figures
115
Customization Available
Yes, the report can be customized as per your need.
Global Small-Molecule Drug Discovery Market Report Segments:
The global Small-Molecule Drug Discovery market is segmented on the basis of:
Types
Pills, Tablets, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Oncology, Cardiovascular, Dermatology, Central Nervous System, Respiratory, Gastrointestinal, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Merck
- Bristol-Myers Squibb
- GlaxoSmithKline
- Boehringer Ingelheim
- AstraZeneca
- Johnson & Johnson
- Teva Pharmaceuticals
- Gilead Sciences Inc.
Highlights of The Small-Molecule Drug Discovery Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Pills
- Tablets
- Others
- By Application:
- Oncology
- Cardiovascular
- Dermatology
- Central Nervous System
- Respiratory
- Gastrointestinal
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Small-Molecule Drug Discovery Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Small-molecule drug discovery is the process of identifying and developing new drugs using small molecules. These drugs can be used to treat a variety of diseases and conditions, including cancer.
Some of the major companies in the small-molecule drug discovery market are Pfizer, Merck, Bristol-Myers Squibb, GlaxoSmithKline, Boehringer Ingelheim, AstraZeneca, Johnson & Johnson, Teva Pharmaceuticals, Gilead Sciences Inc..
The small-molecule drug discovery market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Small-Molecule Drug Discovery Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Small-Molecule Drug Discovery Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Small-Molecule Drug Discovery Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Small-Molecule Drug Discovery Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Small-Molecule Drug Discovery Market Size & Forecast, 2018-2028
4.5.1 Small-Molecule Drug Discovery Market Size and Y-o-Y Growth
4.5.2 Small-Molecule Drug Discovery Market Absolute $ Opportunity
Chapter 5 Global Small-Molecule Drug Discovery Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Small-Molecule Drug Discovery Market Size Forecast by Type
5.2.1 Pills
5.2.2 Tablets
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Small-Molecule Drug Discovery Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Small-Molecule Drug Discovery Market Size Forecast by Applications
6.2.1 Oncology
6.2.2 Cardiovascular
6.2.3 Dermatology
6.2.4 Central Nervous System
6.2.5 Respiratory
6.2.6 Gastrointestinal
6.2.7 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Small-Molecule Drug Discovery Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Small-Molecule Drug Discovery Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Small-Molecule Drug Discovery Analysis and Forecast
9.1 Introduction
9.2 North America Small-Molecule Drug Discovery Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Small-Molecule Drug Discovery Market Size Forecast by Type
9.6.1 Pills
9.6.2 Tablets
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Small-Molecule Drug Discovery Market Size Forecast by Applications
9.10.1 Oncology
9.10.2 Cardiovascular
9.10.3 Dermatology
9.10.4 Central Nervous System
9.10.5 Respiratory
9.10.6 Gastrointestinal
9.10.7 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Small-Molecule Drug Discovery Analysis and Forecast
10.1 Introduction
10.2 Europe Small-Molecule Drug Discovery Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Small-Molecule Drug Discovery Market Size Forecast by Type
10.6.1 Pills
10.6.2 Tablets
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Small-Molecule Drug Discovery Market Size Forecast by Applications
10.10.1 Oncology
10.10.2 Cardiovascular
10.10.3 Dermatology
10.10.4 Central Nervous System
10.10.5 Respiratory
10.10.6 Gastrointestinal
10.10.7 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Small-Molecule Drug Discovery Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Small-Molecule Drug Discovery Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Small-Molecule Drug Discovery Market Size Forecast by Type
11.6.1 Pills
11.6.2 Tablets
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Small-Molecule Drug Discovery Market Size Forecast by Applications
11.10.1 Oncology
11.10.2 Cardiovascular
11.10.3 Dermatology
11.10.4 Central Nervous System
11.10.5 Respiratory
11.10.6 Gastrointestinal
11.10.7 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Small-Molecule Drug Discovery Analysis and Forecast
12.1 Introduction
12.2 Latin America Small-Molecule Drug Discovery Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Small-Molecule Drug Discovery Market Size Forecast by Type
12.6.1 Pills
12.6.2 Tablets
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Small-Molecule Drug Discovery Market Size Forecast by Applications
12.10.1 Oncology
12.10.2 Cardiovascular
12.10.3 Dermatology
12.10.4 Central Nervous System
12.10.5 Respiratory
12.10.6 Gastrointestinal
12.10.7 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Small-Molecule Drug Discovery Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Small-Molecule Drug Discovery Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Small-Molecule Drug Discovery Market Size Forecast by Type
13.6.1 Pills
13.6.2 Tablets
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Small-Molecule Drug Discovery Market Size Forecast by Applications
13.10.1 Oncology
13.10.2 Cardiovascular
13.10.3 Dermatology
13.10.4 Central Nervous System
13.10.5 Respiratory
13.10.6 Gastrointestinal
13.10.7 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Small-Molecule Drug Discovery Market: Competitive Dashboard
14.2 Global Small-Molecule Drug Discovery Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 Merck
14.3.3 Bristol-Myers Squibb
14.3.4 GlaxoSmithKline
14.3.5 Boehringer Ingelheim
14.3.6 AstraZeneca
14.3.7 Johnson & Johnson
14.3.8 Teva Pharmaceuticals
14.3.9 Gilead Sciences Inc.
